Sign In
News Digest /
StockInvest.us
Author: StockInvest.us
06:10pm, Tuesday, Aug 12, 2025
Beyond Air, Inc. (NASDAQ: XAIR) - Quick read
What's happening inside: commercial rollout of the LungFit® PH is generating early revenue and international distribution deals, management is cutting operating spend, but the company remains loss-making with tight liquidity and an expensive loan facil...
06:09pm, Tuesday, Aug 12, 2025
NeuroPace, Inc. (NASDAQ: NPCE) - quick read on what's happening inside the company and the income statement.
Snapshot - facts & figures (as reported, all $ in thousands unless noted)
* Q2 2025 revenue: $23,520 (up 22% vs Q2 2024); 6‑month revenue: $46,044 (up 23% YoY).
* Q2 2025 gross profit: $18...
06:07pm, Tuesday, Aug 12, 2025
ClearPoint Neuro, Inc. (NASDAQ: CLPT) - Quick internal read
What's happening inside: management is scaling commercialization (SmartFrame OR, Prism laser, OS 3.0) and biologics/drug‑delivery services while investing heavily in R&D and commercial headcount. In May 2025 the company completed a smal...
06:06pm, Tuesday, Aug 12, 2025
Mineralys Therapeutics, Inc. (NASDAQ: MLYS) - quick read
Snapshot - what's happening inside
* Company is a clinical‑stage biotech focused on lorundrostat (aldosterone synthase inhibitor) across uncontrolled/resistant hypertension, CKD and obstructive sleep apnea.
* Pivotal trials Launch‑HTN and ...
06:05pm, Tuesday, Aug 12, 2025
Knightscope, Inc. (NASDAQ: KSCP) - Quick read on what's happening inside
All numbers from the company's Form 10‑Q for quarter ended June 30, 2025 (amounts presented in the filing are in thousands except share and per‑share data).
Snapshot - situation at a glance
* Cash and cash equivalents (6/30/...
06:04pm, Tuesday, Aug 12, 2025
Zevra Therapeutics, Inc. (NASDAQ: KMPH)
Quick take: Management converted FDA approval into commercial revenue (MIPLYFFA), monetized a transferable PRV for a one‑time $148.3M net gain that materially improved cash and profit for the quarter, but wrote down an acquired product intangible (OLPRUVA) ...
06:03pm, Tuesday, Aug 12, 2025
Surf Air Mobility Inc. (NYSE: SRFM) - quick read on what's happening inside
Snapshot - what's changing inside the company
* Management is shrinking costs and exiting unprofitable scheduled and on‑demand routes to improve unit economics.
* Company continues technology and aircraft-electrification ...
06:02pm, Tuesday, Aug 12, 2025
Salarius Pharmaceuticals, Inc. (NASDAQ: SLRX) - snapshot
What's happening inside: management has sharply cut R&D and G&A costs, pursued a strategic merger with Decoy Therapeutics and an equity line (ELOC) to raise cash, but the company remains a pre‑revenue clinical-stage biotech with going‑conce...
06:02pm, Tuesday, Aug 12, 2025
Snapshot - Lucid Diagnostics Inc. (NASDAQ: LUCD)
Short take: Lucid is a commercial-stage diagnostics company pushing EsoGuard/EsoCheck to market. The business is showing clinical traction and reimbursement momentum but remains cash‑burning, loss-making and dependent on additional financing and pa...
06:01pm, Tuesday, Aug 12, 2025
Willow Lane Acquisition Corp. (NASDAQ: WLACU) - quick take: a recently IPO'd SPAC with a large trust account producing non‑operating income, limited operating cash outside the trust, no operating revenues and a hard deadline to complete a business combination.
Key facts & figures
* Cash (outside ...
05:25pm, Tuesday, Aug 12, 2025
Stran & Company, Inc. (NASDAQ: STRN) - Quick take
Short summary: management is scaling revenue aggressively (organic + acquisition) and returned to profitability in 2025, but margins and internal controls show pressure from the Gander Group acquisition and recent operational changes.
Key facts & ...
05:24pm, Tuesday, Aug 12, 2025
Company: Citius Pharmaceuticals, Inc. (NASDAQ: CTXR)
What's happening inside the company
- Citius is transitioning from development to commercial stage - FDA-approved LYMPHIR (denileukin diftitox) (approval Aug 8, 2024) and preparing a U.S. commercial launch targeted for Q4 2025.
- The majority-o...
05:23pm, Tuesday, Aug 12, 2025
Snapshot - Annovis Bio, Inc. (NYSE: ANVS)
Quick take: management is advancing a pivotal Phase 3 Alzheimer's trial while burning cash. A successful February 2025 equity raise temporarily rebuilt the balance sheet, but the company still discloses substantial doubt about its ability to continue as a...
05:22pm, Tuesday, Aug 12, 2025
Stratus Properties Inc. (NASDAQ: STRS) - quick read on what's happening inside
Snapshot
* Company type: Residential & retail-focused developer/operator based in Austin, Texas.
* Report: Form 10‑Q for quarter ended June 30, 2025.
Key financials (reported, in thousands)
* Total assets: $574,821
* C...
05:21pm, Tuesday, Aug 12, 2025
Snapshot - ALT5 Sigma Corporation (NASDAQ: JAN)
What's happening inside: management is executing an aggressive fintech roll‑up (ALT5 Subsidiary May 2024; Qoden Nov 2024; Mswipe May 9, 2025), while formally separating its biotech arm (Alyea) as discontinued operations. The company is pursuing larg...
